Yves A. De Clerck

1.3k total citations
14 papers, 1.1k citations indexed

About

Yves A. De Clerck is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yves A. De Clerck has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yves A. De Clerck's work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (4 papers). Yves A. De Clerck is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (5 papers) and Cell Adhesion Molecules Research (4 papers). Yves A. De Clerck collaborates with scholars based in United States, France and Germany. Yves A. De Clerck's co-authors include Keith Langley, K E Langley, Thomas C. Boone, Martin Johnson, Peter A. Jones, Barry Ratzkin, Toshiyuki Yoneda, Paul J. Williams, Frieder Bauss and Akira Sasaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yves A. De Clerck

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yves A. De Clerck United States	11	643	577	370	208	188	14	1.1k
Anna T. Levy United States	7	820 1.3×	604 1.0×	477 1.3×	241 1.2×	277 1.5×	8	1.2k
Sara Monea United States	9	636 1.0×	381 0.7×	386 1.0×	261 1.3×	206 1.1×	10	1.1k
K Danø Denmark	8	854 1.3×	607 1.1×	425 1.1×	249 1.2×	549 2.9×	8	1.3k
Erkki Hujanen Finland	13	315 0.5×	395 0.7×	342 0.9×	75 0.4×	342 1.8×	16	1.0k
R.S. Lemons United States	8	376 0.6×	238 0.4×	871 2.4×	224 1.1×	183 1.0×	9	1.3k
Laurence Blavier United States	17	757 1.2×	779 1.4×	830 2.2×	151 0.7×	164 0.9×	21	1.7k
Regina Maki Sasahara Brazil	9	751 1.2×	510 0.9×	701 1.9×	169 0.8×	175 0.9×	10	1.3k
M. Eber France	14	356 0.6×	420 0.7×	265 0.7×	108 0.5×	160 0.9×	24	793
Marc A. Lafleur Australia	15	461 0.7×	314 0.5×	400 1.1×	209 1.0×	221 1.2×	20	921
Carlo Hojilla Canada	12	504 0.8×	811 1.4×	732 2.0×	67 0.3×	199 1.1×	19	1.5k

Countries citing papers authored by Yves A. De Clerck

Since Specialization

Citations

This map shows the geographic impact of Yves A. De Clerck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves A. De Clerck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves A. De Clerck more than expected).

Fields of papers citing papers by Yves A. De Clerck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves A. De Clerck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves A. De Clerck. The network helps show where Yves A. De Clerck may publish in the future.

Co-authorship network of co-authors of Yves A. De Clerck

This figure shows the co-authorship network connecting the top 25 collaborators of Yves A. De Clerck. A scholar is included among the top collaborators of Yves A. De Clerck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves A. De Clerck. Yves A. De Clerck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Clerck, Yves A. De, et al.. (2024). The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies. SHILAP Revista de lepidopterología. 3. 100161–100161. 6 indexed citations

Clerck, Yves A. De, Ofelia Álvarez, Hiroyuki Shimada, Shirley M. Taylor, & Keith Langley. (2015). Tissue Inhibitors of Metalloproteinases: Role in Tumor Progression1. Contributions to nephrology. 107. 108–115.

Clerck, Yves A. De, Bernard E. Weissman, Dihua Yu, et al.. (2006). Tumor progression and metastasis from genetic to microenvironmental determinants. Cancer Biology & Therapy. 5(12). 1588–1599. 1 indexed citations

Yoneda, Toshiyuki, Akira Sasaki, Colin R. Dunstan, et al.. (1997). Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.. Journal of Clinical Investigation. 99(10). 2509–2517. 211 indexed citations

Clerck, Yves A. De, Martine I. Darville, Yves Eeckhout, & Guy Rousseau. (1994). Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene. 139(2). 185–191. 102 indexed citations

Clerck, Yves A. De, Hiroyuki Shimada, Shirley M. Taylor, & Keith Langley. (1994). Matrix Metalloproteinases and Their Inhibitors in Tumor Progression^a. Annals of the New York Academy of Sciences. 732(1). 222–232. 43 indexed citations

Clerck, Yves A. De, Hiroyuki Shimada, Ignacio González-Gómez, & Corey Raffel. (1993). Tumoral invasion in the central nervous system. Journal of Neuro-Oncology. 18(2). 111–121. 35 indexed citations

Polette, Myriam, Christine Clavel, Philippe Birembaut, & Yves A. De Clerck. (1993). Localization by In Situ Hybridization of mRNAs Encoding Stromelysin 3 and Tissue Inhibitors of Metallo-Proteinases TIMP-1 and TIMP-2 in Human Head and Neck Carcinomas*. Pathology - Research and Practice. 189(9). 1052–1057. 67 indexed citations

Montgomery, A M, Yves A. De Clerck, K E Langley, R. Reisfeld, & Barbara M. Mueller. (1993). Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.. PubMed. 53(3). 693–700. 94 indexed citations

10.

Boone, Thomas C., Martin Johnson, Yves A. De Clerck, & Keith Langley. (1990). cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.. Proceedings of the National Academy of Sciences. 87(7). 2800–2804. 178 indexed citations

11.

Clerck, Yves A. De, et al.. (1989). Purification and Characterization of Two Related but Distinct Metalloproteinase Inhibitors Secreted by Bovine Aortic Endothelial Cells. Journal of Biological Chemistry. 264(29). 17445–17453. 178 indexed citations

12.

Bogenmann, Emil, Hart Isaacs, Harry B. Neustein, et al.. (1983). Invasive properties of primary pediatric neoplasms in vitro.. PubMed. 43(3). 1176–86. 21 indexed citations

13.

Clerck, Yves A. De, et al.. (1982). Extracellular matrix destruction by invasive tumor cells. Cancer and Metastasis Reviews. 1(4). 289–317. 95 indexed citations

14.

Clerck, Yves A. De & Peter A. Jones. (1980). The effect of ascorbic acid on the nature and production of collagen and elastin by rat smooth-muscle cells. Biochemical Journal. 186(1). 217–225. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact